5OHD
 
 | | Putative inactive (dormant) dimeric state of GHR transmembrane domain | | 分子名称: | Growth hormone receptor | | 著者 | Lesovoy, D.M, Bocharov, E.V, Bocharova, O.V, Urban, A.S, Arseniev, A.S. | | 登録日 | 2017-07-15 | | 公開日 | 2018-04-11 | | 最終更新日 | 2024-07-03 | | 実験手法 | SOLUTION NMR | | 主引用文献 | Structural basis of the signal transduction via transmembrane domain of the human growth hormone receptor.
Biochim. Biophys. Acta, 1862, 2018
|
|
5OEK
 | | Putative active dimeric state of GHR transmembrane domain | | 分子名称: | Growth hormone receptor | | 著者 | Lesovoy, D.M, Bocharov, E.V, Bocharova, O.V, Urban, A.S, Arseniev, A.S. | | 登録日 | 2017-07-08 | | 公開日 | 2018-04-11 | | 最終更新日 | 2024-07-03 | | 実験手法 | SOLUTION NMR | | 主引用文献 | Structural basis of the signal transduction via transmembrane domain of the human growth hormone receptor.
Biochim. Biophys. Acta, 1862, 2018
|
|
2LLM
 | |
2M0B
 | | Homodimeric transmembrane domain of the human receptor tyrosine kinase ErbB1 (EGFR, HER1) in micelles | | 分子名称: | Epidermal growth factor receptor | | 著者 | Lesovoy, D.M, Bocharov, E.V, Pustovalova, Y.E, Bocharova, O.V, Arseniev, A.S. | | 登録日 | 2012-10-24 | | 公開日 | 2013-10-30 | | 最終更新日 | 2024-05-01 | | 実験手法 | SOLUTION NMR | | 主引用文献 | Alternative packing of EGFR transmembrane domain suggests that protein-lipid interactions underlie signal conduction across membrane.
Biochim. Biophys. Acta, 1858, 2016
|
|
2KS1
 | | Heterodimeric association of Transmembrane domains of ErbB1 and ErbB2 receptors Enabling Kinase Activation | | 分子名称: | Epidermal growth factor receptor, Receptor tyrosine-protein kinase erbB-2 | | 著者 | Mineev, K.S, Bocharov, E.V, Pustovalova, Y.E, Bocharova, O.V, Chupin, V.V, Arseniev, A.S. | | 登録日 | 2009-12-24 | | 公開日 | 2010-06-09 | | 最終更新日 | 2024-05-01 | | 実験手法 | SOLUTION NMR | | 主引用文献 | Spatial Structure of the Transmembrane Domain Heterodimer of ErbB1 and ErbB2 Receptor Tyrosine Kinases
J.Mol.Biol., 2010
|
|
7PH8
 | |
7PL4
 | |
7PHT
 | |
2N2A
 | | Spatial structure of HER2/ErbB2 dimeric transmembrane domain in the presence of cytoplasmic juxtamembrane domains | | 分子名称: | Receptor tyrosine-protein kinase erbB-2 | | 著者 | Bragin, P.E, Mineev, K.S, Bocharov, E, Bocharova, O, Arseniev, A. | | 登録日 | 2015-05-05 | | 公開日 | 2016-02-24 | | 最終更新日 | 2024-05-15 | | 実験手法 | SOLUTION NMR | | 主引用文献 | HER2 Transmembrane Domain Dimerization Coupled with Self-Association of Membrane-Embedded Cytoplasmic Juxtamembrane Regions.
J.Mol.Biol., 428, 2016
|
|
2N5S
 | |
5LV6
 | | N-terminal motif dimerization of EGFR transmembrane domain in bicellar environment | | 分子名称: | Epidermal growth factor receptor | | 著者 | Bragin, P, Bocharov, E, Mineev, K, Bocharova, O, Arseniev, A. | | 登録日 | 2016-09-12 | | 公開日 | 2017-04-05 | | 最終更新日 | 2024-06-19 | | 実験手法 | SOLUTION NMR | | 主引用文献 | The Conformation of the Epidermal Growth Factor Receptor Transmembrane Domain Dimer Dynamically Adapts to the Local Membrane Environment.
Biochemistry, 56, 2017
|
|
2LOH
 | |
7B3K
 | | Dynamic complex between all-D-enantiomeric peptide D3 with L723P mutant of amyloid precursor protein (APP) 672-726 fragment (amyloid beta 1-55) | | 分子名称: | D3 all D-enantimeric peptide, Isoform L-APP677 of Amyloid-beta precursor protein | | 著者 | Bocharov, E.V, Volynsky, P.E, Okhrimenko, I.S, Urban, A.S. | | 登録日 | 2020-12-01 | | 公開日 | 2021-01-13 | | 最終更新日 | 2023-06-14 | | 実験手法 | SOLUTION NMR | | 主引用文献 | All - d - Enantiomeric Peptide D3 Designed for Alzheimer's Disease Treatment Dynamically Interacts with Membrane-Bound Amyloid-beta Precursors.
J.Med.Chem., 64, 2021
|
|
7B3J
 | | Dynamic complex between all-D-enantiomeric peptide D3 with wild-type amyloid precursor protein 672-726 fragment (amyloid beta 1-55) | | 分子名称: | D3 all D-enantimeric peptide, Isoform L-APP677 of Amyloid-beta precursor protein | | 著者 | Bocharov, E.V, Volynsky, P.E, Okhrimenko, I.S, Urban, A.S. | | 登録日 | 2020-12-01 | | 公開日 | 2021-01-13 | | 最終更新日 | 2021-12-08 | | 実験手法 | SOLUTION NMR | | 主引用文献 | All - d - Enantiomeric Peptide D3 Designed for Alzheimer's Disease Treatment Dynamically Interacts with Membrane-Bound Amyloid-beta Precursors.
J.Med.Chem., 64, 2021
|
|
5OB4
 | |
